Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 8/20 | 0.48 |
| ▸ | RPS6KB1 | P23443 | 7/20 | 0.48 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8304320 | 0.86 | ALDH1A1 (0.49) | AURKARPS6KB1AURKBMAPK1ALDH1A1 | |
| SCHEMBL6327136 | 0.83 | POLB (0.46) | AURKARPS6KB1AURKBMAPK1ALDH1A1 | |
| SCHEMBL6329960 | 0.81 | F10 (0.48) | AURKARPS6KB1AURKBMAPK1CNR1 | |
| SCHEMBL8307208 | 0.80 | F10 (0.48) | AURKARPS6KB1AURKBLMNAHPGD | |
| Hydrochloric Acid SCHEMBL6326766 | 0.80 | F10 (0.48) | AURKARPS6KB1AURKBMAPK1CNR1 | |
| SCHEMBL6325892 | 0.80 | F10 (0.48) | AURKARPS6KB1AURKBLMNAHPGD | |
| SCHEMBL6329487 | 0.80 | AURKA (0.43) | AURKARPS6KB1AURKBMAPK1ALDH1A1 | |
| SCHEMBL6322361 | 0.80 | AURKA (0.49) | AURKARPS6KB1AURKBLMNAHPGD | |
| Hydrochloric Acid SCHEMBL6325502 | 0.80 | F10 (0.47) | AURKARPS6KB1AURKBLMNAHPGD | |
| SCHEMBL6324688 | 0.77 | F10 (0.43) | ALDH1A1LMNAHPGDSMN1; SMN2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9089477-B2 | Storage-stable formulation of paracetamol in aqueous solution | Neogen N.V. (BE) | 2015-07-28 | — | — | US | disclosed |
| US-20130317112-A1 | STORAGE-STABLE FORMULATION OF PARACETAMOL IN AQUEOUS SOLUTION | Neogen N.V. (BE) | 2013-11-28 | — | — | US | disclosed |
| US-20050119151-A1 | Textile cleaning agent which is gentle on textiles | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-06-02 | — | — | US | disclosed |
| US-20050107409-A1 | Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-05-19 | — | — | US | disclosed |
| WO-2004080970-A1 | NOVEL BICYCLIC AROMATIC COMPOUNDS, THE PRODUCTION AND USE THEREOF IN THE FORM OF DRUGS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2004-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107409-A1 | Aromatic bicyclic compounds, preparation thereof and their use as pharmaceutical compositions | F12, F2, F11 | AURKA 437/4885RPS6KB1 2064/4885AURKB 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.